Noel K Miner

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The primary treatment for Parkinson's disease is dopaminergic stimulation. Although levodopa has historically been administered orally, maintaining a predictable plasma concentration of the drug is challenging. As a result, enteral administration of carbidopa/levodopa (Duopa) has emerged as a promising tool in the treatment of the disease. This requires(More)
  • 1